SCYNEXIS Inc (NASDAQ:SCYX)
| 1.85 BATS BZX Real-Time Price As of 3:17pm ET |  +0.03 / +1.65%Today’s Change | 1.15 Today|||52-Week Range 4.95 | +18.59% Year-to-Date |
Latest SCYX News | Press Releases
No recent news for SCYNEXIS Inc.
Today’s Trading
| Previous close | 1.82 |
| Today’s open | 1.75 |
| Day’s range | 1.75 - 1.96 |
| Volume | 32,651 |
| Average volume (3 months) | 321,093 |
| Market cap | $41.6M |
Data as of 3:13pm ET, 03/24/2023
Growth & Valuation
| Earnings growth (last year) | +75.80% |
| Earnings growth (this year) | -25.60% |
| Earnings growth (next 5 years) | +256.00% |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | 12.23 |
| Price/Book | 0.89 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| --Herantis Pharma Oyj | 0.00 | 0.00% |
| ---- | ||
| TCRRTCR2 Therapeutics In... | +0.09 | +6.69% |
| ASMBAssembly Biosciences... | -0.03 | -3.26% |
Data as of 3:22pm ET, 03/24/2023
Financials
| Last reporting date | March 24, 2023 |
| EPS forecast (this quarter) | -$0.39 |
| Annual revenue (last year) | $13.2M |
| Annual profit (last year) | -$32.9M |
| Net profit margin | -249.68% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Jersey City, New Jersey |
Forecasts
